Adiponectin upregulates ferritin heavy chain in skeletal muscle cells

Diabetes

Volumn 58, Issue 1, 2009, Pages 61-70

  Ikegami, Yuichi ^a   Inukai, Kouichi ^a   Imai, Kenta ^a   Sakamoto, Yasushi ^a   Katagiri, Hideki ^b   Kurihara, Susumu ^a   Awata, Takuya ^a   Katayama, Shigehiro ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CERULOPLASMIN; FATTY ACID; FERRITIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MANGANESE SUPEROXIDE DISMUTASE; PROTEIN SUBUNIT; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; APOFERRITIN; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HEAVY CHAIN; LIGHT CHAIN; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SKELETAL MUSCLE; TWO DIMENSIONAL ELECTROPHORESIS; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION; GENETICS; METABOLISM; PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

ADIPONECTIN; ANIMALS; APOFERRITINS; BLOTTING, WESTERN; CELLS, CULTURED; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION; MICE; MUSCLE, SKELETAL; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHORYLATION; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SUPEROXIDE DISMUTASE;

EID: 63249131619     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db07-0690     Document Type: Article

References (42)

1. Guerre-Millo M: Adipose tissue and adipokines: for better or worse. Diabetes Metab 30:13-19, 2004
2. Shapiro L, Scherer PE: The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor. Curr Biol 8:335-338, 1998
3. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara H, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T: The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:941-946, 2001
4. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 221:286-289, 1996
5. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T: Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8:1288-1295, 2002
6. Ouchi N, Kihara S, Arita Y, Nishida M, Matsuyama A, Okamoto Y, Ishigami M, Kuriyama H, Kishida K, Nishizawa H, Hotta K, Muraguchi M, Ohmoto Y, Yamashita S, Funahashi T, Matsuzawa Y: Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger eceptor expression in human monocyte-derived macrophages. Circulation 103:1057-1063, 2001
7. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M, Nakamura T, Yamashita S, Funahashi T, Matsu-zawa Y: Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100:2473-2476, 1999
8. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M, Murakami K, Ohteki T, Uchida S, Takekawa S, Waki H, Tsuno NH, Shibata Y, Terauchi Y, Froguel P, Tobe K, Koyasu S, Taira K, Kitamura T, Shimizu T, Nagai R, Kadowaki T: Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423:762-769, 2003
9. Waki H, Yamauchi T, Kamon J, Ito Y, Uchida S, Kita S, Hara K, Hada Y, Vasseur F, Froguel P, Kimura S, Nagai R, Kadowaki T: Impaired multim-erization of human adiponectin mutants associated with diabetes: molecular structure and multimer formation of adiponectin. J Biol Chem 278:40352-40363, 2003
10. Tsao TS, Tomas E, Murrey HE, Hug C, Lee DH, Ruderman NB, Heuser JE, Lodish HF: Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity: different oligomers activate different signal transduction pathways. J Biol Chem 278:50810-50817, 2003
11. Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T, Berger JP, Wagner JA, Wu M, Knopps A, Xiang AH, Utzschneider KM, Kahn SE, Olefsky JM, Buchanan TA, Scherer PE: Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem 279:12152-12162, 2004
12. Kobayashi H, Ouchi N, Kihara S, Walsh K, Kumada M, Abe Y, Funahashi T, Matsuzawa Y: Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res 94:27-31, 2004
13. Lara-Castro C, Luo N, Wallace P, Klein RL, Garvey WT: Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 55:249-259, 2006
14. Nakashima R, Kamei N, Yamane K, Nakanishi S, Nakashima A, Kohno N: Decreased total and high molecular weight adiponectin are independent risk factors for the development of type 2 diabetes in Japanese-Americans. J Clin Endocrinol Metab 91:3873-3877, 2006
15. Arosio P, Levi S: Ferritin, iron homeostasis, and oxidative damage. Free Radic Biol Med 33:457-463, 2002
16. Torti FM, Torti SV: Regulation of ferritin genes and protein. Blood 99:3505-3516, 2002
17. Pham CG, Bubici C, Zazzeroni F, Papa S, Jones J, Alvarez K, Jayawardena S, De Smaele E, Cong R, Beaumont C, Torti FM, Torti SV, Franzoso G: Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species. Cell 119:529 -542, 2004
18. Sinha S, Perdomo G, Brown NF, O'Doherty RM: Fatty acid-induced insulin resistance in L6 myotubes is prevented by inhibition of activation and nuclear localization of nuclear factor kappa B. JBiol Chem 279:41294-41301, 2004
19. Inukai K, Shewan AM, Pascow WS, Katayama S, James DE, Oka Y: Carboxy terminus of glucose transporter 3 contains an apical membrane targeting domain. Mol Endocrinol 18:339-349, 2004
20. Miyake S, Makimura M, Kanegae Y, Harada S, Sato Y, Takamori K, Tokuda C, Saito I: Efficient generation of recombinant adenoviruses using adeno-virus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc Natl Acad SciUSA 93:1320-1324, 1996
21. Inukai K, Nakashima Y, Watanabe M, Takata N, Sawa T, Kurihara S, Awata T, Katayama S: Regulation of adiponectin receptor gene expression in diabetic mice. Am J Physiol Endocrinol Metab 288:E876-E882, 2005
22. Kwak EL, Larochelle DA, Beaumont C, Torti SV, Torti FM: Role for NF-kappa B in the regulation of ferritin H by tumor necrosis factor-alpha. J Biol Chem 270:15285-15293, 1995
23. Bevilacqua MA, Faniello MC, Quaresima B, Tiano MT, Giuliano P, Fel-iciello A, Avvedimento VE, Cimino F, Costanzo F: A common mechanism underlying the E1A repression and the cAMP stimulation of the H ferritin transcription. J Biol Chem 272:20736-20741, 1997
24. Hattori Y, Hattori S, Kasai K: Globular adiponectin activates nuclear factor-kappa B in vascular endothelial cells, which in turn induces expression of proinflammatory and adhesion molecule genes. Diabetes Care 29:139-141, 2006
25. McConell GK, Bradley SJ, Stephens TJ, Canny BJ, Kingwell BA, Lee-Young RS:Skeletal muscle nNOS|μ protein content is increased by exercise training in humans. Am J Physiol Regul Integr Comp Physiol 293:R831-R828, 2007
26. Yoon MJ, Lee GY, Chung JJ, Ahn YH, Hong SH, Kim JB: Adiponectin increased fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor α. Diabetes 55: 2562-2570, 2006
27. Barnes PJ, Karin M: Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066-1071, 1997
28. Makarov SS: NF-kappaB as a therapeutic target in chronic inflammation: recent advances. Mol Med Today 6:441-448, 2000
29. Hayden MS, West AP, Ghosh S: NF-kappaB and the immune response. Oncogene 25:6758-6780, 2006
30. Orino K, Lehman L, Tsuji Y, Ayaki H, Torti SV, Torti FM: Ferritin and the response to oxidative stress. Biochem J 357:241-247, 2001
31. Bevilacqua MA, Faniello MC, Russo T, Cimino F, Costanzo F: Transcriptional regulation of the human H ferritin-encoding gene (FERH) in G418-treated cells: role of the B-box-binding factor. Gene 141:287-291, 1994
32. Cozzi A, Corsi B, Levi S, Santambrogio P, Albertini A, Arosio P: Overex- pression of wild type and mutated human ferritin H-chain in HeLa cells: in vivo role of ferritin ferroxidase activity. J Biol Chem 275:25122-25129, 2000
33. Levi S, Luzzago A, Cesareni G Cozze A, Franceschinelli F, Albertini A, Arosio P: Mechanism of ferritin iron uptake: activity of the H-chain and deletion mapping of the ferro-oxidase site: a study of iron uptake and ferro-oxidase activity of human liver, recombinant H-chain ferritins, and of two H-chain deletion mutants. J Biol Chem 263:18086-18092, 1988
34. Tsuji Y, Akebi N, Lam TK, Nakabeppu Y, Torti SV, Torti FM: FER-1, an enhancer of the ferritin H gene and a target of E1A-mediated transcrip-tional repression. Mol Cell Biol 15:5152-5164, 1995
35. Miller LL, Miller SC, Torti SV, Tsuji Y, Torti FM: Iron independent induction of ferritin H-chain by tumor necrosis factor. Proc Natl Acad SciUSA 88:4946-4950, 1991
36. Fargion S, Mattioli M, Fracanzani AL, Sampietro M, Tavazzi D, Fociani P, Taioli E, Valenti L, Fiorelli G: Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis. Am J Gastroenterol 96:2448-2455, 2001
37. Forouhi NG, Harding AH, Allison M, Sandhu MS, Welch A, Luben R, Bingham S, Khaw KT, Wareham NJ: Elevated serum ferritin levels predict new-onset type 2 diabetes: results from the EPIC-Norfolk prospective study. Diabetologia 50:949-956, 2007
38. Kim I, Moon SO, Kim SH, Kim HJ, Koh YS, Koh GY: Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J Biol Chem 276:7614-7620, 2001
39. Lappas M, Permezel M, Georgiou HM, Rice GE: Nuclear factor kappa B regulation of pro-inflammatory cytokines in human gestational tissues in vitro. Biol Reprod 67:668-673, 2002
40. Ho RC, Hirshman MF, Li Y, Cai D, Farmer JR, Aschenbach WG, Witczak CA, Shoelson SE, Goodyear LJ: Regulation of I-KB kinase and NF-κBin contracting adult rat skeletal muscle. Am, J Physiol Cell Physiol 289:C794-C801, 2005
41. Rudich A, Tirosh A, Potashnik R, Hemi R, Kanety H, Bashan N: Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes. Diabetes 47:1562-1569, 1998
42. Houstis N, Rosen ED, Lander ES: Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 440:944 -948, 2006